Bottom line
What is LAMRX's expense ratio?
LAMRX's expense ratio is 1.14%, or about $114 a year on every $10,000 invested. That is more expensive than 79% of dividend & equity income funds we track (median 0.74%). It has no front-end sales load. Its expense ratio includes a 0.5% 12b-1 marketing fee.
Updated Mar 26, 2026
LAMRX fee table
| Net expense ratio | 1.14% |
|---|---|
| Gross expense ratio | 1.14% |
| Management fee | 0.52% |
| 12b-1 (distribution) fee | 0.5% |
| Other expenses | 0.12% |
| Fee waiver / reimbursement | 0% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Mar 26, 2026
What LAMRX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| LAMRX | $116 | $362 | $628 | $1,386 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.14% expense ratio costs roughly $62,400 in lost growth, versus about $41,900 for the median dividend & equity income fund (0.74%).